Jump to content
RemedySpot.com

Re: Breast feeding while on Gleevec

Rate this topic


Guest guest

Recommended Posts

Hi ,

I'm a mother of 4, diagnosed with cml at 22 weeks of pregnancy with my youngest

child, now 7 months old. I'm on this cml boat without buying a ticket for it.

Since when we all have to think on the same lines? I thought that was the idea

of freedom of speech; actual ability to raise ones opinions. I clearly stated

this is my belief. I also believed in myself when I decided to have my baby at

home by myself (no medical assistance) despite doctors not giving me a green

light for home birth. Mind is extremely powerful organ and we can at least try

to control it a bit. I know myself and I know I DID cause my illness, just

getting out of it proved to be a challenge.

Now, if you think I made illiterate, untrue and selfish statement, please prove

it to me if you dare.

From: hey00nanc

Sent: Saturday, October 02, 2010 11:21 PM

Subject: Re: [ ] Breast feeding while on Gleevec

>

> who r u to make such a strong untrue selfish illiterate statement? That

is totally out of line!

> Sent via BlackBerry by AT & T

_____________________________

Remember that this is the same list-mate who recently wrote her opinion that we

create our own diseases (cancers) and that those who are not successful with

treatment have a wish to die prematurely! someone honestly said that.

Just because you believe something, that does not mean that it is true!

it is just something that You believe.

C.

Link to comment
Share on other sites

Unfortunately I'm on the same boat as any other member of this group but not on

the same page, or rather not even in the same book.

If you think it was or is easy for me to be diagnosed with cml at 22 weeks of my

last pregnancy and be a young mother of 4 kids aged 8, 5, 3 years and 7 months

you got it all wrong.

At least most of you have mature families with some grandchildren, something I

may not experience my self so I'm making the most of what I've got now.

The hell with it!

From: onthewtr@...

Sent: Saturday, October 02, 2010 10:19 PM

Subject: Re: [ ] Breast feeding while on Gleevec

who r u to make such a strong untrue selfish illiterate statement? That is

totally out of line!

Sent via BlackBerry by AT & T

[ ] Breast feeding while on Gleevec

I am gravely concerned about a member who posted recently that she was

breast feeding her baby while on Gleevec. I want her to know that I am not

judging her, but merely reiterating what has been passed down to us

repeately. In speaking directly to her, I hope you have permission, dear

member from your doctor or you could be playing Russian roulette with your

baby's health. This is the warning that comes with Gleevec. Women who want

to become pregnant should not do so while taking Gleevec or any other TKI.

If you need further proof, I urge you to please contact the Novartis Hotline

or the instructions that comes in your package. This comes from their

webpage:

Who should NOT take GLEEVEC

Women who are or could be pregnant. Fetal harm can occur when administered

to pregnant women; therefore, women should not become pregnant, as well as

be advised of the potential risk to the unborn child if GLEEVEC is used

during pregnancy.

" Women who are breast-feeding because of the potential for serious adverse

reactions in nursing infants.

" Sexually active females should use adequate birth control while taking

GLEEVEC.

" Be sure to talk to your doctor and/or healthcare professional about these

issues before taking GLEEVEC "

http://tinyurl.com/29fl97v

--_________________

I further give you warnings from the following information published in the

Internet Journal of Oncology. This article was written by Ault MS,

RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner

School of Nursing The University of Texas Health Science Center at Houston

and I quote from her article (noted in 2010 Volume 7 Number 2).

I have known Pat Ault for a long time, also most of the doctors in that

department. She would not have been given permission to write this article

without the blessings of the doctors at MDACC that she works under and I

respect her authority on the subject of CML.

You will note that everything I copied is in " quotations " . Some quotes I

have excerpted are posted here, but the entire article can be seen at the

recited website listed below the quotes, however, it is very lengthy:

" Management of CML during pregnancy poses challenges to both hematologists

and obstetricians. Currently, consensus is lacking in management of CML in

pregnancy; therefore, clinical observations have become important. Most of

these observations are derived from small case series or case reports.

" Therefore, leukapheresis may be an intermittent short-term alternative

option for pregnant patients, and prevents fetal exposure to TERATOGENIC

drugs. However, leukapheresis is cumbersome, costly, and a time consuming

procedure, with risk of infection, thrombosis and hypotensive events that

may affect the fetus and patient.

" ........... high concentrations of imatinib are DETECTED IN BREAST MILK.

" Investigation of the placentas included standard pathologic analysis,

computer assisted morphometry, and fluorescence in situ hybridization (FISH)

analysis. This patient was treated with a targeted tyrosine inhibitor during

first trimester of a first pregnancy and during the third trimester of a

second pregnancy. The umbilical cord blood and breast milk findings were: 1)

low imatinib and metabolite concentration levels found in the umbilical

blood suggest limited placental transfer in late pregnancy, and 2) HIGH

CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST

MILK.

" Rousselot et al (2007) reported imatinib may be discontinued in patients

who achieved a complete molecular remission for a period of at least 2 years

without evidence of disease progression.

" Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN

BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in

infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d);

considering this milk intake and the infants are unlikely to receive more

than 3 mg/d imatinib daily. This amount is far from therapeutic range,

therefore, concluding that mothers with CML could safely breast-feed the

infant. However, the effects of low-dose chronic exposure of infants to

imatinib are not known, and have not undergone long-term investigation;

THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY.

ttp://tinyurl.com/2g82tpc

FYI,

Lottie Duthu

Link to comment
Share on other sites

Sorry anna I thought I signed my name. Research does state that mothers

shouldn't breastfeed and furthermore what I wrote is not from emotional

distress. From the posts everyone is in agreement that your statement about if

mothers don't breastfeed they are poor excuse for a mother was illerate hurtful

and insensetive. Literature from md anderson states that it is possible gleevec

passes through the mothers milk but I guess you are smarter then them. The

website on gleevec states this also. But it was your decision to breastfeed and

that was your business but to make a statement about mothers being poor excuses

for mothers not breastfeeding was way out of line

Everything I typed was in my own words so that really didn't make much sense on

your part

Regards

Penny

Sent from my Verizon Wireless BlackBerry

Re: [ ] Breast feeding while on Gleevec

>

> I agree Zavie. while I don't post much about CML anymore I am concerned with

the absurd theory that if you don't breastfeed you are a bad mother. My own

daughter who just recently gave birth did not make milk for health reasons and

she is a wonderful Mom. Which is worse, no breast or a Mom who can't admit she

isn't making enough milk to sustain her child? I believe I was on the evaporated

milk and karo diet and survived because of a great mom. Everyday at school I

help care for children who were breastfed and now have autism, learning

disabilities etc. Moms who have this bad attitude certainly will not foster

caring children as they grow. Sorry if I hurt anyone but I feel many young

mothers who have to make the decision not to breastfeed are being given a very

bad rap! Lynn F

> [ ] Breast feeding while on Gleevec

>

> I am gravely concerned about a member who posted recently that she was

> breast feeding her baby while on Gleevec. I want her to know that I am not

> judging her, but merely reiterating what has been passed down to us

> repeately. In speaking directly to her, I hope you have permission, dear

> member from your doctor or you could be playing Russian roulette with your

> baby's health. This is the warning that comes with Gleevec. Women who want

> to become pregnant should not do so while taking Gleevec or any other TKI.

> If you need further proof, I urge you to please contact the Novartis Hotline

> or the instructions that comes in your package. This comes from their

> webpage:

>

> Who should NOT take GLEEVEC

> Women who are or could be pregnant. Fetal harm can occur when administered

> to pregnant women; therefore, women should not become pregnant, as well as

> be advised of the potential risk to the unborn child if GLEEVEC is used

> during pregnancy.

>

> " Women who are breast-feeding because of the potential for serious adverse

> reactions in nursing infants.

>

> " Sexually active females should use adequate birth control while taking

> GLEEVEC.

>

> " Be sure to talk to your doctor and/or healthcare professional about these

> issues before taking GLEEVEC "

>

> http://tinyurl.com/29fl97v

> --_________________

>

> I further give you warnings from the following information published in the

> Internet Journal of Oncology. This article was written by Ault MS,

> RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner

> School of Nursing The University of Texas Health Science Center at Houston

> and I quote from her article (noted in 2010 Volume 7 Number 2).

>

> I have known Pat Ault for a long time, also most of the doctors in that

> department. She would not have been given permission to write this article

> without the blessings of the doctors at MDACC that she works under and I

> respect her authority on the subject of CML.

>

> You will note that everything I copied is in " quotations " . Some quotes I

> have excerpted are posted here, but the entire article can be seen at the

> recited website listed below the quotes, however, it is very lengthy:

>

> " Management of CML during pregnancy poses challenges to both hematologists

> and obstetricians. Currently, consensus is lacking in management of CML in

> pregnancy; therefore, clinical observations have become important. Most of

> these observations are derived from small case series or case reports.

>

> " Therefore, leukapheresis may be an intermittent short-term alternative

> option for pregnant patients, and prevents fetal exposure to TERATOGENIC

> drugs. However, leukapheresis is cumbersome, costly, and a time consuming

> procedure, with risk of infection, thrombosis and hypotensive events that

> may affect the fetus and patient.

> " ........... high concentrations of imatinib are DETECTED IN BREAST MILK.

> " Investigation of the placentas included standard pathologic analysis,

> computer assisted morphometry, and fluorescence in situ hybridization (FISH)

> analysis. This patient was treated with a targeted tyrosine inhibitor during

> first trimester of a first pregnancy and during the third trimester of a

> second pregnancy. The umbilical cord blood and breast milk findings were: 1)

> low imatinib and metabolite concentration levels found in the umbilical

> blood suggest limited placental transfer in late pregnancy, and 2) HIGH

> CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST

> MILK.

>

> " Rousselot et al (2007) reported imatinib may be discontinued in patients

> who achieved a complete molecular remission for a period of at least 2 years

> without evidence of disease progression.

>

> " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN

> BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in

> infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d);

> considering this milk intake and the infants are unlikely to receive more

> than 3 mg/d imatinib daily. This amount is far from therapeutic range,

> therefore, concluding that mothers with CML could safely breast-feed the

> infant. However, the effects of low-dose chronic exposure of infants to

> imatinib are not known, and have not undergone long-term investigation;

> THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY.

>

> ttp://tinyurl.com/2g82tpc

>

> FYI,

>

> Lottie Duthu

>

>

Link to comment
Share on other sites

first of all that was me not making that statement. I just read all of

your posts and yes you are entitled to freedom of speech but I do not

believe that you have to be so hurtful in what you say--saying that a mother

that does nurse is a bad mother is not very kind and you have no proof of

that so why say it.

And another thing. you keep referring to most of us being old? how do you

know that? Being old makes us wiser and maybe you should listen to some of

us older ones -=we are older and wiser!!! I am sure you have heard from many

young mothers--not just old people like us!.

Sharon

_____

From: [mailto: ] On Behalf Of

d'Araille

Sent: Sunday, October 03, 2010 6:55 AM

Subject: Re: [ ] Breast feeding while on Gleevec

Hi ,

I'm a mother of 4, diagnosed with cml at 22 weeks of pregnancy with my

youngest child, now 7 months old. I'm on this cml boat without buying a

ticket for it.

Since when we all have to think on the same lines? I thought that was the

idea of freedom of speech; actual ability to raise ones opinions. I clearly

stated this is my belief. I also believed in myself when I decided to have

my baby at home by myself (no medical assistance) despite doctors not giving

me a green light for home birth. Mind is extremely powerful organ and we can

at least try to control it a bit. I know myself and I know I DID cause my

illness, just getting out of it proved to be a challenge.

Now, if you think I made illiterate, untrue and selfish statement, please

prove it to me if you dare.

From: hey00nanc

Sent: Saturday, October 02, 2010 11:21 PM

<mailto:%40>

Subject: Re: [ ] Breast feeding while on Gleevec

--- In <mailto:%40> , onthewtr@...

wrote:

>

> who r u to make such a strong untrue selfish illiterate statement?

That is totally out of line!

> Sent via BlackBerry by AT & T

_____________________________

Remember that this is the same list-mate who recently wrote her opinion that

we create our own diseases (cancers) and that those who are not successful

with treatment have a wish to die prematurely! someone honestly said that.

Just because you believe something, that does not mean that it is true!

it is just something that You believe.

C.

Link to comment
Share on other sites

typo--i meant to say mother that does not nurse!!!

Sharon

_____

From: [mailto: ] On Behalf Of Sharon

Teichera

Sent: Sunday, October 03, 2010 7:35 AM

Subject: RE: [ ] Breast feeding while on Gleevec

first of all that was me not making that statement. I just read all of

your posts and yes you are entitled to freedom of speech but I do not

believe that you have to be so hurtful in what you say--saying that a mother

that does nurse is a bad mother is not very kind and you have no proof of

that so why say it.

And another thing. you keep referring to most of us being old? how do you

know that? Being old makes us wiser and maybe you should listen to some of

us older ones -=we are older and wiser!!! I am sure you have heard from many

young mothers--not just old people like us!.

Sharon

_____

From: <mailto:%40>

[mailto: <mailto:%40> ] On Behalf Of

d'Araille

Sent: Sunday, October 03, 2010 6:55 AM

<mailto:%40>

Subject: Re: [ ] Breast feeding while on Gleevec

Hi ,

I'm a mother of 4, diagnosed with cml at 22 weeks of pregnancy with my

youngest child, now 7 months old. I'm on this cml boat without buying a

ticket for it.

Since when we all have to think on the same lines? I thought that was the

idea of freedom of speech; actual ability to raise ones opinions. I clearly

stated this is my belief. I also believed in myself when I decided to have

my baby at home by myself (no medical assistance) despite doctors not giving

me a green light for home birth. Mind is extremely powerful organ and we can

at least try to control it a bit. I know myself and I know I DID cause my

illness, just getting out of it proved to be a challenge.

Now, if you think I made illiterate, untrue and selfish statement, please

prove it to me if you dare.

From: hey00nanc

Sent: Saturday, October 02, 2010 11:21 PM

<mailto:%40>

<mailto:%40>

Subject: Re: [ ] Breast feeding while on Gleevec

--- In <mailto:%40>

<mailto:%40> , onthewtr@...

wrote:

>

> who r u to make such a strong untrue selfish illiterate statement?

That is totally out of line!

> Sent via BlackBerry by AT & T

_____________________________

Remember that this is the same list-mate who recently wrote her opinion that

we create our own diseases (cancers) and that those who are not successful

with treatment have a wish to die prematurely! someone honestly said that.

Just because you believe something, that does not mean that it is true!

it is just something that You believe.

C.

Link to comment
Share on other sites

,

I don't often post, I have trouble on with certain of my computers but I

borrowed my friend's Mac because this is not a time for silence. First let me

say that I'm sorry you feel that you don't belong in the group. Of course you

belong, you have CML. But that is in many cases the only common thread that

connects us. Yet we become friends and in many cases family. Who else can

really understand the path we walk? Friendships are formed here but even in the

greatest of friendships there may be disagreements. It appears this is one such

time.

You are correct when you say breast feeding is good for children. You are

correct when you say, it is your decision to continue to breast feed. I think

the issue began when you stated that anyone who did not breast feed is a bad

mother.

We have enough struggles with our disease without judging each other and to

paint us as bad mothers is hurtful.

It appears from your post that you did your research but all the journals in

the world cannot predict the future. You say that you are young, then perhaps

you are not aware of the drugs that did not impact the mothers but did give the

daughters cancer as young women. As parents we are charged to do what is right

for our children. We make decisions everyday which hopefully are centered on

the needs of the child; not our own.

We are lucky that CML in chronic phase is slow moving. I probably had it for

almost two years before diagnosis. While I drink green tea daily and have for

about 15 years, I think and it is just my opinion, that you were able to carry

your baby to term and remain off meds due to the slow progression which is the

hallmark of the disease in chronic phase. The story may have had a different

ending if you were in blast phase at diagnosis. I'm not arguing with you, I have

no need to be right. I just want you to consider other view points when you are

making your decisions.

I can tell you are a loving and caring mother. I guess that this discussion is

rendered moot by your statement that you are pretty much dried up and now just

breast feed for comfort. Even as non-scientist we have to believe that something

that can affect us at a genetic level, as Gleevec does, has to be some pretty

strong stuff. You wouldn't take a spoon and feed her a little bit of poison,

even 10%. You state how much you love breast feeding, please consider whose

needs and comfort are being met, if in fact there is no nutritional value and

there may even be harm.

I hope you will stay as a member. I'm sorry if you felt attacked but from where

I sit you lobbed the first round- with the bad mother comment. We all are

connected by our disease. But we can't leave our manners at the door. Are you

aware that we have Skip who has had CML for over 30 years? Or that many of the

people on this list were in the clinical trials for the very medicine that is

keeping you alive? We are fortunate to have a living history of the fight

against this disease. They have so much knowledge. Please stay and benefit

from this knowledge.

One final piece of information if you were in the US, your doctor would probably

have reported you for child endangerment based on all of the warnings documented

by Novartis.

I have no judgement on what kind of a mother you are ; I hope you will extend

the same courtesy to the rest of us - we do the best we can and when we know

better, the hope is that we will do better. I know I try to do better everyday.

China

________________________________

From: d'Araille <darajek@...>

Sent: Sun, October 3, 2010 7:10:37 AM

Subject: Re: [ ] Breast feeding while on Gleevec

Unfortunately I'm on the same boat as any other member of this group but not on

the same page, or rather not even in the same book.

If you think it was or is easy for me to be diagnosed with cml at 22 weeks of my

last pregnancy and be a young mother of 4 kids aged 8, 5, 3 years and 7 months

you got it all wrong.

At least most of you have mature families with some grandchildren, something I

may not experience my self so I'm making the most of what I've got now.

The hell with it!

From: onthewtr@...

Sent: Saturday, October 02, 2010 10:19 PM

Subject: Re: [ ] Breast feeding while on Gleevec

who r u to make such a strong untrue selfish illiterate statement? That is

totally out of line!

Sent via BlackBerry by AT & T

[ ] Breast feeding while on Gleevec

I am gravely concerned about a member who posted recently that she was

breast feeding her baby while on Gleevec. I want her to know that I am not

judging her, but merely reiterating what has been passed down to us

repeately. In speaking directly to her, I hope you have permission, dear

member from your doctor or you could be playing Russian roulette with your

baby's health. This is the warning that comes with Gleevec. Women who want

to become pregnant should not do so while taking Gleevec or any other TKI.

If you need further proof, I urge you to please contact the Novartis Hotline

or the instructions that comes in your package. This comes from their

webpage:

Who should NOT take GLEEVEC

Women who are or could be pregnant. Fetal harm can occur when administered

to pregnant women; therefore, women should not become pregnant, as well as

be advised of the potential risk to the unborn child if GLEEVEC is used

during pregnancy.

" Women who are breast-feeding because of the potential for serious adverse

reactions in nursing infants.

" Sexually active females should use adequate birth control while taking

GLEEVEC.

" Be sure to talk to your doctor and/or healthcare professional about these

issues before taking GLEEVEC "

http://tinyurl.com/29fl97v

--_________________

I further give you warnings from the following information published in the

Internet Journal of Oncology. This article was written by Ault MS,

RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner

School of Nursing The University of Texas Health Science Center at Houston

and I quote from her article (noted in 2010 Volume 7 Number 2).

I have known Pat Ault for a long time, also most of the doctors in that

department. She would not have been given permission to write this article

without the blessings of the doctors at MDACC that she works under and I

respect her authority on the subject of CML.

You will note that everything I copied is in " quotations " . Some quotes I

have excerpted are posted here, but the entire article can be seen at the

recited website listed below the quotes, however, it is very lengthy:

" Management of CML during pregnancy poses challenges to both hematologists

and obstetricians. Currently, consensus is lacking in management of CML in

pregnancy; therefore, clinical observations have become important. Most of

these observations are derived from small case series or case reports.

" Therefore, leukapheresis may be an intermittent short-term alternative

option for pregnant patients, and prevents fetal exposure to TERATOGENIC

drugs. However, leukapheresis is cumbersome, costly, and a time consuming

procedure, with risk of infection, thrombosis and hypotensive events that

may affect the fetus and patient.

" ........... high concentrations of imatinib are DETECTED IN BREAST MILK.

" Investigation of the placentas included standard pathologic analysis,

computer assisted morphometry, and fluorescence in situ hybridization (FISH)

analysis. This patient was treated with a targeted tyrosine inhibitor during

first trimester of a first pregnancy and during the third trimester of a

second pregnancy. The umbilical cord blood and breast milk findings were: 1)

low imatinib and metabolite concentration levels found in the umbilical

blood suggest limited placental transfer in late pregnancy, and 2) HIGH

CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST

MILK.

" Rousselot et al (2007) reported imatinib may be discontinued in patients

who achieved a complete molecular remission for a period of at least 2 years

without evidence of disease progression.

" Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN

BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in

infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d);

considering this milk intake and the infants are unlikely to receive more

than 3 mg/d imatinib daily. This amount is far from therapeutic range,

therefore, concluding that mothers with CML could safely breast-feed the

infant. However, the effects of low-dose chronic exposure of infants to

imatinib are not known, and have not undergone long-term investigation;

THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY.

ttp://tinyurl.com/2g82tpc

FYI,

Lottie Duthu

Link to comment
Share on other sites

I am 38 and have been here since age 33. Mother of 3 children (14,11,9).

In a message dated 10/3/2010 4:43:00 P.M. Central Daylight Time,

formiga101@... writes:

I am 29 and have been part of this group almost 7 years

From: _ryan.romero@..._ (mailto:ryan.romero@...)

<_ryan.romero@..._ (mailto:ryan.romero@...) >

Subject: Re: [ ] Breast feeding while on Gleevec

_ _ (mailto: )

Date: Sunday, October 3, 2010, 1:13 PM

I'm 28

Thanks

[ ] Breast feeding while on Gleevec

>

> I am gravely concerned about a member who posted recently that she was

> breast feeding her baby while on Gleevec. I want her to know that I am

not

> judging her, but merely reiterating what has been passed down to us

> repeately. In speaking directly to her, I hope you have permission, dear

> member from your doctor or you could be playing Russian roulette with

your

> baby's health. This is the warning that comes with Gleevec. Women who

want

> to become pregnant should not do so while taking Gleevec or any other

TKI.

> If you need further proof, I urge you to please contact the Novartis

Hotline

> or the instructions that comes in your package. This comes from their

> webpage:

>

> Who should NOT take GLEEVEC

> Women who are or could be pregnant. Fetal harm can occur when

administered

> to pregnant women; therefore, women should not become pregnant, as well

as

> be advised of the potential risk to the unborn child if GLEEVEC is used

> during pregnancy.

>

> " Women who are breast-feeding because of the potential for serious

adverse

> reactions in nursing infants.

>

> " Sexually active females should use adequate birth control while taking

> GLEEVEC.

>

> " Be sure to talk to your doctor and/or healthcare professional about

these

> issues before taking GLEEVEC "

>

> _http://tinyurl.com/29fl97v_ (http://tinyurl.com/29fl97v)

> --_________________

>

> I further give you warnings from the following information published in

the

> Internet Journal of Oncology. This article was written by Ault

MS,

> RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner

> School of Nursing The University of Texas Health Science Center at

Houston

> and I quote from her article (noted in 2010 Volume 7 Number 2).

>

> I have known Pat Ault for a long time, also most of the doctors in that

> department. She would not have been given permission to write this

article

> without the blessings of the doctors at MDACC that she works under and I

> respect her authority on the subject of CML.

>

> You will note that everything I copied is in " quotations " . Some quotes I

> have excerpted are posted here, but the entire article can be seen at

the

> recited website listed below the quotes, however, it is very lengthy:

>

> " Management of CML during pregnancy poses challenges to both

hematologists

> and obstetricians. Currently, consensus is lacking in management of CML

in

> pregnancy; therefore, clinical observations have become important. Most

of

> these observations are derived from small case series or case reports.

>

> " Therefore, leukapheresis may be an intermittent short-term alternative

> option for pregnant patients, and prevents fetal exposure to TERATOGENIC

> drugs. However, leukapheresis is cumbersome, costly, and a time

consuming

> procedure, with risk of infection, thrombosis and hypotensive events

that

> may affect the fetus and patient.

> " ........... high concentrations of imatinib are DETECTED IN BREAST

MILK.

> " Investigation of the placentas included standard pathologic analysis,

> computer assisted morphometry, and fluorescence in situ hybridization

(FISH)

> analysis. This patient was treated with a targeted tyrosine inhibitor

during

> first trimester of a first pregnancy and during the third trimester of a

> second pregnancy. The umbilical cord blood and breast milk findings

were:

1)

> low imatinib and metabolite concentration levels found in the umbilical

> blood suggest limited placental transfer in late pregnancy, and 2) HIGH

> CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE

BREAST

> MILK.

>

> " Rousselot et al (2007) reported imatinib may be discontinued in

patients

> who achieved a complete molecular remission for a period of at least 2

years

> without evidence of disease progression.

>

> " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION

IN

> BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake

in

> infants is known to average 728 to 777 ml/d, (range of 450 to 1165

ml/d);

> considering this milk intake and the infants are unlikely to receive

more

> than 3 mg/d imatinib daily. This amount is far from therapeutic range,

> therefore, concluding that mothers with CML could safely breast-feed the

> infant. However, the effects of low-dose chronic exposure of infants to

> imatinib are not known, and have not undergone long-term investigation;

> THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING

THERAPY.

>

> _ttp://tinyurl.com/2g82tpc_ (ttp://tinyurl.com/2g82tpc)

>

> FYI,

>

> Lottie Duthu

>

> [Non-text portions of this message have been removed]

>

> [Non-text portions of this message have been removed]

>

> [Non-text portions of this message have been removed]

>

> [Non-text portions of this message have been removed]

>

> [Non-text portions of this message have been removed]

>

> [Non-text portions of this message have been removed]

>

>

>

>

>

>

>

> [Non-text portions of this message have been removed]

>

[Non-text portions of this message have been removed]

[Non-text portions of this message have been removed]

[Non-text portions of this message have been removed]

Link to comment
Share on other sites

I'm done with this group. It should be called CML-support offered to over 60's

only, no baby related subjects allowed.

>

> ,

>

> I don't often post, I have trouble on with certain of my computers but I

> borrowed my friend's Mac because this is not a time for silence. First let me

> say that I'm sorry you feel that you don't belong in the group. Of course you

> belong, you have CML. But that is in many cases the only common thread that

> connects us. Yet we become friends and in many cases family. Who else can

> really understand the path we walk? Friendships are formed here but even in

the

> greatest of friendships there may be disagreements. It appears this is one

such

> time.

>

> You are correct when you say breast feeding is good for children. You are

> correct when you say, it is your decision to continue to breast feed. I think

> the issue began when you stated that anyone who did not breast feed is a bad

> mother.

>

> We have enough struggles with our disease without judging each other and to

> paint us as bad mothers is hurtful.

>

> It appears from your post that you did your research but all the journals in

> the world cannot predict the future. You say that you are young, then perhaps

> you are not aware of the drugs that did not impact the mothers but did give

the

> daughters cancer as young women. As parents we are charged to do what is

right

> for our children. We make decisions everyday which hopefully are centered on

> the needs of the child; not our own.

>

> We are lucky that CML in chronic phase is slow moving. I probably had it for

> almost two years before diagnosis. While I drink green tea daily and have for

> about 15 years, I think and it is just my opinion, that you were able to carry

> your baby to term and remain off meds due to the slow progression which is the

> hallmark of the disease in chronic phase. The story may have had a different

> ending if you were in blast phase at diagnosis. I'm not arguing with you, I

have

> no need to be right. I just want you to consider other view points when you

are

> making your decisions.

>

> I can tell you are a loving and caring mother. I guess that this discussion

is

> rendered moot by your statement that you are pretty much dried up and now just

> breast feed for comfort. Even as non-scientist we have to believe that

something

> that can affect us at a genetic level, as Gleevec does, has to be some pretty

> strong stuff. You wouldn't take a spoon and feed her a little bit of poison,

> even 10%. You state how much you love breast feeding, please consider whose

> needs and comfort are being met, if in fact there is no nutritional value and

> there may even be harm.

>

> I hope you will stay as a member. I'm sorry if you felt attacked but from

where

> I sit you lobbed the first round- with the bad mother comment. We all are

> connected by our disease. But we can't leave our manners at the door. Are

you

> aware that we have Skip who has had CML for over 30 years? Or that many of

the

> people on this list were in the clinical trials for the very medicine that is

> keeping you alive? We are fortunate to have a living history of the fight

> against this disease. They have so much knowledge. Please stay and benefit

> from this knowledge.

>

> One final piece of information if you were in the US, your doctor would

probably

> have reported you for child endangerment based on all of the warnings

documented

> by Novartis.

>

> I have no judgement on what kind of a mother you are ; I hope you will extend

> the same courtesy to the rest of us - we do the best we can and when we know

> better, the hope is that we will do better. I know I try to do better

everyday.

>

> China

>

>

>

> ________________________________

> From: d'Araille <darajek@...>

>

> Sent: Sun, October 3, 2010 7:10:37 AM

> Subject: Re: [ ] Breast feeding while on Gleevec

>

>

> Unfortunately I'm on the same boat as any other member of this group but not

on

> the same page, or rather not even in the same book.

> If you think it was or is easy for me to be diagnosed with cml at 22 weeks of

my

> last pregnancy and be a young mother of 4 kids aged 8, 5, 3 years and 7 months

> you got it all wrong.

> At least most of you have mature families with some grandchildren, something I

> may not experience my self so I'm making the most of what I've got now.

> The hell with it!

>

>

> From: onthewtr@...

> Sent: Saturday, October 02, 2010 10:19 PM

>

> Subject: Re: [ ] Breast feeding while on Gleevec

>

> who r u to make such a strong untrue selfish illiterate statement? That

is

> totally out of line!

>

> Sent via BlackBerry by AT & T

>

> [ ] Breast feeding while on Gleevec

>

> I am gravely concerned about a member who posted recently that she was

> breast feeding her baby while on Gleevec. I want her to know that I am not

> judging her, but merely reiterating what has been passed down to us

> repeately. In speaking directly to her, I hope you have permission, dear

> member from your doctor or you could be playing Russian roulette with your

> baby's health. This is the warning that comes with Gleevec. Women who want

> to become pregnant should not do so while taking Gleevec or any other TKI.

> If you need further proof, I urge you to please contact the Novartis Hotline

> or the instructions that comes in your package. This comes from their

> webpage:

>

> Who should NOT take GLEEVEC

> Women who are or could be pregnant. Fetal harm can occur when administered

> to pregnant women; therefore, women should not become pregnant, as well as

> be advised of the potential risk to the unborn child if GLEEVEC is used

> during pregnancy.

>

> " Women who are breast-feeding because of the potential for serious adverse

> reactions in nursing infants.

>

> " Sexually active females should use adequate birth control while taking

> GLEEVEC.

>

> " Be sure to talk to your doctor and/or healthcare professional about these

> issues before taking GLEEVEC "

>

> http://tinyurl.com/29fl97v

> --_________________

>

> I further give you warnings from the following information published in the

> Internet Journal of Oncology. This article was written by Ault MS,

> RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner

> School of Nursing The University of Texas Health Science Center at Houston

> and I quote from her article (noted in 2010 Volume 7 Number 2).

>

> I have known Pat Ault for a long time, also most of the doctors in that

> department. She would not have been given permission to write this article

> without the blessings of the doctors at MDACC that she works under and I

> respect her authority on the subject of CML.

>

> You will note that everything I copied is in " quotations " . Some quotes I

> have excerpted are posted here, but the entire article can be seen at the

> recited website listed below the quotes, however, it is very lengthy:

>

> " Management of CML during pregnancy poses challenges to both hematologists

> and obstetricians. Currently, consensus is lacking in management of CML in

> pregnancy; therefore, clinical observations have become important. Most of

> these observations are derived from small case series or case reports.

>

> " Therefore, leukapheresis may be an intermittent short-term alternative

> option for pregnant patients, and prevents fetal exposure to TERATOGENIC

> drugs. However, leukapheresis is cumbersome, costly, and a time consuming

> procedure, with risk of infection, thrombosis and hypotensive events that

> may affect the fetus and patient.

> " ........... high concentrations of imatinib are DETECTED IN BREAST MILK.

> " Investigation of the placentas included standard pathologic analysis,

> computer assisted morphometry, and fluorescence in situ hybridization (FISH)

> analysis. This patient was treated with a targeted tyrosine inhibitor during

> first trimester of a first pregnancy and during the third trimester of a

> second pregnancy. The umbilical cord blood and breast milk findings were: 1)

> low imatinib and metabolite concentration levels found in the umbilical

> blood suggest limited placental transfer in late pregnancy, and 2) HIGH

> CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST

> MILK.

>

> " Rousselot et al (2007) reported imatinib may be discontinued in patients

> who achieved a complete molecular remission for a period of at least 2 years

> without evidence of disease progression.

>

> " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN

> BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in

> infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d);

> considering this milk intake and the infants are unlikely to receive more

> than 3 mg/d imatinib daily. This amount is far from therapeutic range,

> therefore, concluding that mothers with CML could safely breast-feed the

> infant. However, the effects of low-dose chronic exposure of infants to

> imatinib are not known, and have not undergone long-term investigation;

> THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY.

>

> ttp://tinyurl.com/2g82tpc

>

> FYI,

>

> Lottie Duthu

>

>

Link to comment
Share on other sites

I agree with the baby subject however, I am 30 and get a lot of useful

information from everyone that posts on here!

Thanks,

Sent from my Verizon Wireless BlackBerry

[ ] Breast feeding while on Gleevec

>

> I am gravely concerned about a member who posted recently that she was

> breast feeding her baby while on Gleevec. I want her to know that I am not

> judging her, but merely reiterating what has been passed down to us

> repeately. In speaking directly to her, I hope you have permission, dear

> member from your doctor or you could be playing Russian roulette with your

> baby's health. This is the warning that comes with Gleevec. Women who want

> to become pregnant should not do so while taking Gleevec or any other TKI.

> If you need further proof, I urge you to please contact the Novartis Hotline

> or the instructions that comes in your package. This comes from their

> webpage:

>

> Who should NOT take GLEEVEC

> Women who are or could be pregnant. Fetal harm can occur when administered

> to pregnant women; therefore, women should not become pregnant, as well as

> be advised of the potential risk to the unborn child if GLEEVEC is used

> during pregnancy.

>

> " Women who are breast-feeding because of the potential for serious adverse

> reactions in nursing infants.

>

> " Sexually active females should use adequate birth control while taking

> GLEEVEC.

>

> " Be sure to talk to your doctor and/or healthcare professional about these

> issues before taking GLEEVEC "

>

> http://tinyurl.com/29fl97v

> --_________________

>

> I further give you warnings from the following information published in the

> Internet Journal of Oncology. This article was written by Ault MS,

> RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner

> School of Nursing The University of Texas Health Science Center at Houston

> and I quote from her article (noted in 2010 Volume 7 Number 2).

>

> I have known Pat Ault for a long time, also most of the doctors in that

> department. She would not have been given permission to write this article

> without the blessings of the doctors at MDACC that she works under and I

> respect her authority on the subject of CML.

>

> You will note that everything I copied is in " quotations " . Some quotes I

> have excerpted are posted here, but the entire article can be seen at the

> recited website listed below the quotes, however, it is very lengthy:

>

> " Management of CML during pregnancy poses challenges to both hematologists

> and obstetricians. Currently, consensus is lacking in management of CML in

> pregnancy; therefore, clinical observations have become important. Most of

> these observations are derived from small case series or case reports.

>

> " Therefore, leukapheresis may be an intermittent short-term alternative

> option for pregnant patients, and prevents fetal exposure to TERATOGENIC

> drugs. However, leukapheresis is cumbersome, costly, and a time consuming

> procedure, with risk of infection, thrombosis and hypotensive events that

> may affect the fetus and patient.

> " ........... high concentrations of imatinib are DETECTED IN BREAST MILK.

> " Investigation of the placentas included standard pathologic analysis,

> computer assisted morphometry, and fluorescence in situ hybridization (FISH)

> analysis. This patient was treated with a targeted tyrosine inhibitor during

> first trimester of a first pregnancy and during the third trimester of a

> second pregnancy. The umbilical cord blood and breast milk findings were: 1)

> low imatinib and metabolite concentration levels found in the umbilical

> blood suggest limited placental transfer in late pregnancy, and 2) HIGH

> CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST

> MILK.

>

> " Rousselot et al (2007) reported imatinib may be discontinued in patients

> who achieved a complete molecular remission for a period of at least 2 years

> without evidence of disease progression.

>

> " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN

> BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in

> infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d);

> considering this milk intake and the infants are unlikely to receive more

> than 3 mg/d imatinib daily. This amount is far from therapeutic range,

> therefore, concluding that mothers with CML could safely breast-feed the

> infant. However, the effects of low-dose chronic exposure of infants to

> imatinib are not known, and have not undergone long-term investigation;

> THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY.

>

> ttp://tinyurl.com/2g82tpc

>

> FYI,

>

> Lottie Duthu

>

>

Link to comment
Share on other sites

i do not believe that all of us are over 60--help someone-speak up!!!!

_____

From: [mailto: ] On Behalf Of

Mumminki

Sent: Sunday, October 03, 2010 12:18 PM

Subject: Re: [ ] Breast feeding while on Gleevec

I'm done with this group. It should be called CML-support offered to over

60's only, no baby related subjects allowed.

>

> ,

>

> I don't often post, I have trouble on with certain of my computers

but I

> borrowed my friend's Mac because this is not a time for silence. First let

me

> say that I'm sorry you feel that you don't belong in the group. Of course

you

> belong, you have CML. But that is in many cases the only common thread

that

> connects us. Yet we become friends and in many cases family. Who else can

> really understand the path we walk? Friendships are formed here but even

in the

> greatest of friendships there may be disagreements. It appears this is one

such

> time.

>

> You are correct when you say breast feeding is good for children. You are

> correct when you say, it is your decision to continue to breast feed. I

think

> the issue began when you stated that anyone who did not breast feed is a

bad

> mother.

>

> We have enough struggles with our disease without judging each other and

to

> paint us as bad mothers is hurtful.

>

> It appears from your post that you did your research but all the journals

in

> the world cannot predict the future. You say that you are young, then

perhaps

> you are not aware of the drugs that did not impact the mothers but did

give the

> daughters cancer as young women. As parents we are charged to do what is

right

> for our children. We make decisions everyday which hopefully are centered

on

> the needs of the child; not our own.

>

> We are lucky that CML in chronic phase is slow moving. I probably had it

for

> almost two years before diagnosis. While I drink green tea daily and have

for

> about 15 years, I think and it is just my opinion, that you were able to

carry

> your baby to term and remain off meds due to the slow progression which is

the

> hallmark of the disease in chronic phase. The story may have had a

different

> ending if you were in blast phase at diagnosis. I'm not arguing with you,

I have

> no need to be right. I just want you to consider other view points when

you are

> making your decisions.

>

> I can tell you are a loving and caring mother. I guess that this

discussion is

> rendered moot by your statement that you are pretty much dried up and now

just

> breast feed for comfort. Even as non-scientist we have to believe that

something

> that can affect us at a genetic level, as Gleevec does, has to be some

pretty

> strong stuff. You wouldn't take a spoon and feed her a little bit of

poison,

> even 10%. You state how much you love breast feeding, please consider

whose

> needs and comfort are being met, if in fact there is no nutritional value

and

> there may even be harm.

>

> I hope you will stay as a member. I'm sorry if you felt attacked but from

where

> I sit you lobbed the first round- with the bad mother comment. We all are

> connected by our disease. But we can't leave our manners at the door. Are

you

> aware that we have Skip who has had CML for over 30 years? Or that many of

the

> people on this list were in the clinical trials for the very medicine that

is

> keeping you alive? We are fortunate to have a living history of the fight

> against this disease. They have so much knowledge. Please stay and benefit

> from this knowledge.

>

> One final piece of information if you were in the US, your doctor would

probably

> have reported you for child endangerment based on all of the warnings

documented

> by Novartis.

>

> I have no judgement on what kind of a mother you are ; I hope you will

extend

> the same courtesy to the rest of us - we do the best we can and when we

know

> better, the hope is that we will do better. I know I try to do better

everyday.

>

> China

>

>

>

> ________________________________

> From: d'Araille <darajek@...>

> <mailto:%40>

> Sent: Sun, October 3, 2010 7:10:37 AM

> Subject: Re: [ ] Breast feeding while on Gleevec

>

>

> Unfortunately I'm on the same boat as any other member of this group but

not on

> the same page, or rather not even in the same book.

> If you think it was or is easy for me to be diagnosed with cml at 22 weeks

of my

> last pregnancy and be a young mother of 4 kids aged 8, 5, 3 years and 7

months

> you got it all wrong.

> At least most of you have mature families with some grandchildren,

something I

> may not experience my self so I'm making the most of what I've got now.

> The hell with it!

>

>

> From: onthewtr@...

> Sent: Saturday, October 02, 2010 10:19 PM

> <mailto:%40>

> Subject: Re: [ ] Breast feeding while on Gleevec

>

> who r u to make such a strong untrue selfish illiterate statement?

That is

> totally out of line!

>

> Sent via BlackBerry by AT & T

>

> [ ] Breast feeding while on Gleevec

>

> I am gravely concerned about a member who posted recently that she was

> breast feeding her baby while on Gleevec. I want her to know that I am not

> judging her, but merely reiterating what has been passed down to us

> repeately. In speaking directly to her, I hope you have permission, dear

> member from your doctor or you could be playing Russian roulette with your

> baby's health. This is the warning that comes with Gleevec. Women who want

> to become pregnant should not do so while taking Gleevec or any other TKI.

> If you need further proof, I urge you to please contact the Novartis

Hotline

> or the instructions that comes in your package. This comes from their

> webpage:

>

> Who should NOT take GLEEVEC

> Women who are or could be pregnant. Fetal harm can occur when administered

> to pregnant women; therefore, women should not become pregnant, as well as

> be advised of the potential risk to the unborn child if GLEEVEC is used

> during pregnancy.

>

> " Women who are breast-feeding because of the potential for serious adverse

> reactions in nursing infants.

>

> " Sexually active females should use adequate birth control while taking

> GLEEVEC.

>

> " Be sure to talk to your doctor and/or healthcare professional about these

> issues before taking GLEEVEC "

>

> http://tinyurl.com/29fl97v

> --_________________

>

> I further give you warnings from the following information published in

the

> Internet Journal of Oncology. This article was written by Ault

MS,

> RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner

> School of Nursing The University of Texas Health Science Center at Houston

> and I quote from her article (noted in 2010 Volume 7 Number 2).

>

> I have known Pat Ault for a long time, also most of the doctors in that

> department. She would not have been given permission to write this article

> without the blessings of the doctors at MDACC that she works under and I

> respect her authority on the subject of CML.

>

> You will note that everything I copied is in " quotations " . Some quotes I

> have excerpted are posted here, but the entire article can be seen at the

> recited website listed below the quotes, however, it is very lengthy:

>

> " Management of CML during pregnancy poses challenges to both hematologists

> and obstetricians. Currently, consensus is lacking in management of CML in

> pregnancy; therefore, clinical observations have become important. Most of

> these observations are derived from small case series or case reports.

>

> " Therefore, leukapheresis may be an intermittent short-term alternative

> option for pregnant patients, and prevents fetal exposure to TERATOGENIC

> drugs. However, leukapheresis is cumbersome, costly, and a time consuming

> procedure, with risk of infection, thrombosis and hypotensive events that

> may affect the fetus and patient.

> " ........... high concentrations of imatinib are DETECTED IN BREAST MILK.

> " Investigation of the placentas included standard pathologic analysis,

> computer assisted morphometry, and fluorescence in situ hybridization

(FISH)

> analysis. This patient was treated with a targeted tyrosine inhibitor

during

> first trimester of a first pregnancy and during the third trimester of a

> second pregnancy. The umbilical cord blood and breast milk findings were:

1)

> low imatinib and metabolite concentration levels found in the umbilical

> blood suggest limited placental transfer in late pregnancy, and 2) HIGH

> CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST

> MILK.

>

> " Rousselot et al (2007) reported imatinib may be discontinued in patients

> who achieved a complete molecular remission for a period of at least 2

years

> without evidence of disease progression.

>

> " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN

> BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in

> infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d);

> considering this milk intake and the infants are unlikely to receive more

> than 3 mg/d imatinib daily. This amount is far from therapeutic range,

> therefore, concluding that mothers with CML could safely breast-feed the

> infant. However, the effects of low-dose chronic exposure of infants to

> imatinib are not known, and have not undergone long-term investigation;

> THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING

THERAPY.

>

> ttp://tinyurl.com/2g82tpc

>

> FYI,

>

> Lottie Duthu

>

>

Link to comment
Share on other sites

thank you

Sharon

_____

From: [mailto: ] On Behalf Of

rnmichelle80@...

Sent: Sunday, October 03, 2010 12:43 PM

Subject: Re: [ ] Breast feeding while on Gleevec

I agree with the baby subject however, I am 30 and get a lot of useful

information from everyone that posts on here!

Thanks,

Sent from my Verizon Wireless BlackBerry

[ ] Breast feeding while on Gleevec

>

> I am gravely concerned about a member who posted recently that she was

> breast feeding her baby while on Gleevec. I want her to know that I am not

> judging her, but merely reiterating what has been passed down to us

> repeately. In speaking directly to her, I hope you have permission, dear

> member from your doctor or you could be playing Russian roulette with your

> baby's health. This is the warning that comes with Gleevec. Women who want

> to become pregnant should not do so while taking Gleevec or any other TKI.

> If you need further proof, I urge you to please contact the Novartis

Hotline

> or the instructions that comes in your package. This comes from their

> webpage:

>

> Who should NOT take GLEEVEC

> Women who are or could be pregnant. Fetal harm can occur when administered

> to pregnant women; therefore, women should not become pregnant, as well as

> be advised of the potential risk to the unborn child if GLEEVEC is used

> during pregnancy.

>

> " Women who are breast-feeding because of the potential for serious adverse

> reactions in nursing infants.

>

> " Sexually active females should use adequate birth control while taking

> GLEEVEC.

>

> " Be sure to talk to your doctor and/or healthcare professional about these

> issues before taking GLEEVEC "

>

> http://tinyurl.com/29fl97v

> --_________________

>

> I further give you warnings from the following information published in

the

> Internet Journal of Oncology. This article was written by Ault

MS,

> RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner

> School of Nursing The University of Texas Health Science Center at Houston

> and I quote from her article (noted in 2010 Volume 7 Number 2).

>

> I have known Pat Ault for a long time, also most of the doctors in that

> department. She would not have been given permission to write this article

> without the blessings of the doctors at MDACC that she works under and I

> respect her authority on the subject of CML.

>

> You will note that everything I copied is in " quotations " . Some quotes I

> have excerpted are posted here, but the entire article can be seen at the

> recited website listed below the quotes, however, it is very lengthy:

>

> " Management of CML during pregnancy poses challenges to both hematologists

> and obstetricians. Currently, consensus is lacking in management of CML in

> pregnancy; therefore, clinical observations have become important. Most of

> these observations are derived from small case series or case reports.

>

> " Therefore, leukapheresis may be an intermittent short-term alternative

> option for pregnant patients, and prevents fetal exposure to TERATOGENIC

> drugs. However, leukapheresis is cumbersome, costly, and a time consuming

> procedure, with risk of infection, thrombosis and hypotensive events that

> may affect the fetus and patient.

> " ........... high concentrations of imatinib are DETECTED IN BREAST MILK.

> " Investigation of the placentas included standard pathologic analysis,

> computer assisted morphometry, and fluorescence in situ hybridization

(FISH)

> analysis. This patient was treated with a targeted tyrosine inhibitor

during

> first trimester of a first pregnancy and during the third trimester of a

> second pregnancy. The umbilical cord blood and breast milk findings were:

1)

> low imatinib and metabolite concentration levels found in the umbilical

> blood suggest limited placental transfer in late pregnancy, and 2) HIGH

> CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST

> MILK.

>

> " Rousselot et al (2007) reported imatinib may be discontinued in patients

> who achieved a complete molecular remission for a period of at least 2

years

> without evidence of disease progression.

>

> " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN

> BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in

> infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d);

> considering this milk intake and the infants are unlikely to receive more

> than 3 mg/d imatinib daily. This amount is far from therapeutic range,

> therefore, concluding that mothers with CML could safely breast-feed the

> infant. However, the effects of low-dose chronic exposure of infants to

> imatinib are not known, and have not undergone long-term investigation;

> THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING

THERAPY.

>

> ttp://tinyurl.com/2g82tpc

>

> FYI,

>

> Lottie Duthu

>

>

Link to comment
Share on other sites

I'm 28

Thanks

[ ] Breast feeding while on Gleevec

>

> I am gravely concerned about a member who posted recently that she was

> breast feeding her baby while on Gleevec. I want her to know that I am not

> judging her, but merely reiterating what has been passed down to us

> repeately. In speaking directly to her, I hope you have permission, dear

> member from your doctor or you could be playing Russian roulette with your

> baby's health. This is the warning that comes with Gleevec. Women who want

> to become pregnant should not do so while taking Gleevec or any other TKI.

> If you need further proof, I urge you to please contact the Novartis

Hotline

> or the instructions that comes in your package. This comes from their

> webpage:

>

> Who should NOT take GLEEVEC

> Women who are or could be pregnant. Fetal harm can occur when administered

> to pregnant women; therefore, women should not become pregnant, as well as

> be advised of the potential risk to the unborn child if GLEEVEC is used

> during pregnancy.

>

> " Women who are breast-feeding because of the potential for serious adverse

> reactions in nursing infants.

>

> " Sexually active females should use adequate birth control while taking

> GLEEVEC.

>

> " Be sure to talk to your doctor and/or healthcare professional about these

> issues before taking GLEEVEC "

>

> http://tinyurl.com/29fl97v

> --_________________

>

> I further give you warnings from the following information published in

the

> Internet Journal of Oncology. This article was written by Ault

MS,

> RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner

> School of Nursing The University of Texas Health Science Center at Houston

> and I quote from her article (noted in 2010 Volume 7 Number 2).

>

> I have known Pat Ault for a long time, also most of the doctors in that

> department. She would not have been given permission to write this article

> without the blessings of the doctors at MDACC that she works under and I

> respect her authority on the subject of CML.

>

> You will note that everything I copied is in " quotations " . Some quotes I

> have excerpted are posted here, but the entire article can be seen at the

> recited website listed below the quotes, however, it is very lengthy:

>

> " Management of CML during pregnancy poses challenges to both hematologists

> and obstetricians. Currently, consensus is lacking in management of CML in

> pregnancy; therefore, clinical observations have become important. Most of

> these observations are derived from small case series or case reports.

>

> " Therefore, leukapheresis may be an intermittent short-term alternative

> option for pregnant patients, and prevents fetal exposure to TERATOGENIC

> drugs. However, leukapheresis is cumbersome, costly, and a time consuming

> procedure, with risk of infection, thrombosis and hypotensive events that

> may affect the fetus and patient.

> " ........... high concentrations of imatinib are DETECTED IN BREAST MILK.

> " Investigation of the placentas included standard pathologic analysis,

> computer assisted morphometry, and fluorescence in situ hybridization

(FISH)

> analysis. This patient was treated with a targeted tyrosine inhibitor

during

> first trimester of a first pregnancy and during the third trimester of a

> second pregnancy. The umbilical cord blood and breast milk findings were:

1)

> low imatinib and metabolite concentration levels found in the umbilical

> blood suggest limited placental transfer in late pregnancy, and 2) HIGH

> CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST

> MILK.

>

> " Rousselot et al (2007) reported imatinib may be discontinued in patients

> who achieved a complete molecular remission for a period of at least 2

years

> without evidence of disease progression.

>

> " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN

> BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in

> infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d);

> considering this milk intake and the infants are unlikely to receive more

> than 3 mg/d imatinib daily. This amount is far from therapeutic range,

> therefore, concluding that mothers with CML could safely breast-feed the

> infant. However, the effects of low-dose chronic exposure of infants to

> imatinib are not known, and have not undergone long-term investigation;

> THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING

THERAPY.

>

> ttp://tinyurl.com/2g82tpc

>

> FYI,

>

> Lottie Duthu

>

>

Link to comment
Share on other sites

I am 29 and have been part of this group almost 7 years

--- On Sun, 10/3/10, ryan.romero@... <ryan.romero@...>

wrote:

From: ryan.romero@... <ryan.romero@...>

Subject: Re: [ ] Breast feeding while on Gleevec

Date: Sunday, October 3, 2010, 1:13 PM

 

I'm 28

Thanks

[ ] Breast feeding while on Gleevec

>

> I am gravely concerned about a member who posted recently that she was

> breast feeding her baby while on Gleevec. I want her to know that I am not

> judging her, but merely reiterating what has been passed down to us

> repeately. In speaking directly to her, I hope you have permission, dear

> member from your doctor or you could be playing Russian roulette with your

> baby's health. This is the warning that comes with Gleevec. Women who want

> to become pregnant should not do so while taking Gleevec or any other TKI.

> If you need further proof, I urge you to please contact the Novartis

Hotline

> or the instructions that comes in your package. This comes from their

> webpage:

>

> Who should NOT take GLEEVEC

> Women who are or could be pregnant. Fetal harm can occur when administered

> to pregnant women; therefore, women should not become pregnant, as well as

> be advised of the potential risk to the unborn child if GLEEVEC is used

> during pregnancy.

>

> " Women who are breast-feeding because of the potential for serious adverse

> reactions in nursing infants.

>

> " Sexually active females should use adequate birth control while taking

> GLEEVEC.

>

> " Be sure to talk to your doctor and/or healthcare professional about these

> issues before taking GLEEVEC "

>

> http://tinyurl.com/29fl97v

> --_________________

>

> I further give you warnings from the following information published in

the

> Internet Journal of Oncology. This article was written by Ault

MS,

> RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner

> School of Nursing The University of Texas Health Science Center at Houston

> and I quote from her article (noted in 2010 Volume 7 Number 2).

>

> I have known Pat Ault for a long time, also most of the doctors in that

> department. She would not have been given permission to write this article

> without the blessings of the doctors at MDACC that she works under and I

> respect her authority on the subject of CML.

>

> You will note that everything I copied is in " quotations " . Some quotes I

> have excerpted are posted here, but the entire article can be seen at the

> recited website listed below the quotes, however, it is very lengthy:

>

> " Management of CML during pregnancy poses challenges to both hematologists

> and obstetricians. Currently, consensus is lacking in management of CML in

> pregnancy; therefore, clinical observations have become important. Most of

> these observations are derived from small case series or case reports.

>

> " Therefore, leukapheresis may be an intermittent short-term alternative

> option for pregnant patients, and prevents fetal exposure to TERATOGENIC

> drugs. However, leukapheresis is cumbersome, costly, and a time consuming

> procedure, with risk of infection, thrombosis and hypotensive events that

> may affect the fetus and patient.

> " ........... high concentrations of imatinib are DETECTED IN BREAST MILK.

> " Investigation of the placentas included standard pathologic analysis,

> computer assisted morphometry, and fluorescence in situ hybridization

(FISH)

> analysis. This patient was treated with a targeted tyrosine inhibitor

during

> first trimester of a first pregnancy and during the third trimester of a

> second pregnancy. The umbilical cord blood and breast milk findings were:

1)

> low imatinib and metabolite concentration levels found in the umbilical

> blood suggest limited placental transfer in late pregnancy, and 2) HIGH

> CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST

> MILK.

>

> " Rousselot et al (2007) reported imatinib may be discontinued in patients

> who achieved a complete molecular remission for a period of at least 2

years

> without evidence of disease progression.

>

> " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN

> BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in

> infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d);

> considering this milk intake and the infants are unlikely to receive more

> than 3 mg/d imatinib daily. This amount is far from therapeutic range,

> therefore, concluding that mothers with CML could safely breast-feed the

> infant. However, the effects of low-dose chronic exposure of infants to

> imatinib are not known, and have not undergone long-term investigation;

> THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING

THERAPY.

>

> ttp://tinyurl.com/2g82tpc

>

> FYI,

>

> Lottie Duthu

>

>

Link to comment
Share on other sites

Thank u !

Sent via BlackBerry by AT & T

[ ] Breast feeding while on Gleevec

>

> I am gravely concerned about a member who posted recently that she was

> breast feeding her baby while on Gleevec. I want her to know that I am

not

> judging her, but merely reiterating what has been passed down to us

> repeately. In speaking directly to her, I hope you have permission, dear

> member from your doctor or you could be playing Russian roulette with

your

> baby's health. This is the warning that comes with Gleevec. Women who

want

> to become pregnant should not do so while taking Gleevec or any other

TKI.

> If you need further proof, I urge you to please contact the Novartis

Hotline

> or the instructions that comes in your package. This comes from their

> webpage:

>

> Who should NOT take GLEEVEC

> Women who are or could be pregnant. Fetal harm can occur when

administered

> to pregnant women; therefore, women should not become pregnant, as well

as

> be advised of the potential risk to the unborn child if GLEEVEC is used

> during pregnancy.

>

> " Women who are breast-feeding because of the potential for serious

adverse

> reactions in nursing infants.

>

> " Sexually active females should use adequate birth control while taking

> GLEEVEC.

>

> " Be sure to talk to your doctor and/or healthcare professional about

these

> issues before taking GLEEVEC "

>

>_http://tinyurl.com/29fl97v_ (http://tinyurl.com/29fl97v)

> --_________________

>

> I further give you warnings from the following information published in

the

> Internet Journal of Oncology. This article was written by Ault

MS,

> RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner

> School of Nursing The University of Texas Health Science Center at

Houston

> and I quote from her article (noted in 2010 Volume 7 Number 2).

>

> I have known Pat Ault for a long time, also most of the doctors in that

> department. She would not have been given permission to write this

article

> without the blessings of the doctors at MDACC that she works under and I

> respect her authority on the subject of CML.

>

> You will note that everything I copied is in " quotations " . Some quotes I

> have excerpted are posted here, but the entire article can be seen at

the

> recited website listed below the quotes, however, it is very lengthy:

>

> " Management of CML during pregnancy poses challenges to both

hematologists

> and obstetricians. Currently, consensus is lacking in management of CML

in

> pregnancy; therefore, clinical observations have become important. Most

of

> these observations are derived from small case series or case reports.

>

> " Therefore, leukapheresis may be an intermittent short-term alternative

> option for pregnant patients, and prevents fetal exposure to TERATOGENIC

> drugs. However, leukapheresis is cumbersome, costly, and a time

consuming

> procedure, with risk of infection, thrombosis and hypotensive events

that

> may affect the fetus and patient.

> " ........... high concentrations of imatinib are DETECTED IN BREAST

MILK.

> " Investigation of the placentas included standard pathologic analysis,

> computer assisted morphometry, and fluorescence in situ hybridization

(FISH)

> analysis. This patient was treated with a targeted tyrosine inhibitor

during

> first trimester of a first pregnancy and during the third trimester of a

> second pregnancy. The umbilical cord blood and breast milk findings

were:

1)

> low imatinib and metabolite concentration levels found in the umbilical

> blood suggest limited placental transfer in late pregnancy, and 2) HIGH

> CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE

BREAST

> MILK.

>

> " Rousselot et al (2007) reported imatinib may be discontinued in

patients

> who achieved a complete molecular remission for a period of at least 2

years

> without evidence of disease progression.

>

> " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION

IN

> BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake

in

> infants is known to average 728 to 777 ml/d, (range of 450 to 1165

ml/d);

> considering this milk intake and the infants are unlikely to receive

more

> than 3 mg/d imatinib daily. This amount is far from therapeutic range,

> therefore, concluding that mothers with CML could safely breast-feed the

> infant. However, the effects of low-dose chronic exposure of infants to

> imatinib are not known, and have not undergone long-term investigation;

> THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING

THERAPY.

>

>_ttp://tinyurl.com/2g82tpc_ (ttp://tinyurl.com/2g82tpc)

>

> FYI,

>

> Lottie Duthu

>

> [Non-text portions of this message have been removed]

>

> [Non-text portions of this message have been removed]

>

> [Non-text portions of this message have been removed]

>

> [Non-text portions of this message have been removed]

>

> [Non-text portions of this message have been removed]

>

> [Non-text portions of this message have been removed]

>

>

>

>

>

>

>

> [Non-text portions of this message have been removed]

>

[Non-text portions of this message have been removed]

[Non-text portions of this message have been removed]

[Non-text portions of this message have been removed]

Link to comment
Share on other sites

Thank u

Sent via BlackBerry by AT & T

[ ] Breast feeding while on Gleevec

>

> I am gravely concerned about a member who posted recently that she was

> breast feeding her baby while on Gleevec. I want her to know that I am not

> judging her, but merely reiterating what has been passed down to us

> repeately. In speaking directly to her, I hope you have permission, dear

> member from your doctor or you could be playing Russian roulette with your

> baby's health. This is the warning that comes with Gleevec. Women who want

> to become pregnant should not do so while taking Gleevec or any other TKI.

> If you need further proof, I urge you to please contact the Novartis

Hotline

> or the instructions that comes in your package. This comes from their

> webpage:

>

> Who should NOT take GLEEVEC

> Women who are or could be pregnant. Fetal harm can occur when administered

> to pregnant women; therefore, women should not become pregnant, as well as

> be advised of the potential risk to the unborn child if GLEEVEC is used

> during pregnancy.

>

> " Women who are breast-feeding because of the potential for serious adverse

> reactions in nursing infants.

>

> " Sexually active females should use adequate birth control while taking

> GLEEVEC.

>

> " Be sure to talk to your doctor and/or healthcare professional about these

> issues before taking GLEEVEC "

>

> http://tinyurl.com/29fl97v

> --_________________

>

> I further give you warnings from the following information published in

the

> Internet Journal of Oncology. This article was written by Ault

MS,

> RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner

> School of Nursing The University of Texas Health Science Center at Houston

> and I quote from her article (noted in 2010 Volume 7 Number 2).

>

> I have known Pat Ault for a long time, also most of the doctors in that

> department. She would not have been given permission to write this article

> without the blessings of the doctors at MDACC that she works under and I

> respect her authority on the subject of CML.

>

> You will note that everything I copied is in " quotations " . Some quotes I

> have excerpted are posted here, but the entire article can be seen at the

> recited website listed below the quotes, however, it is very lengthy:

>

> " Management of CML during pregnancy poses challenges to both hematologists

> and obstetricians. Currently, consensus is lacking in management of CML in

> pregnancy; therefore, clinical observations have become important. Most of

> these observations are derived from small case series or case reports.

>

> " Therefore, leukapheresis may be an intermittent short-term alternative

> option for pregnant patients, and prevents fetal exposure to TERATOGENIC

> drugs. However, leukapheresis is cumbersome, costly, and a time consuming

> procedure, with risk of infection, thrombosis and hypotensive events that

> may affect the fetus and patient.

> " ........... high concentrations of imatinib are DETECTED IN BREAST MILK.

> " Investigation of the placentas included standard pathologic analysis,

> computer assisted morphometry, and fluorescence in situ hybridization

(FISH)

> analysis. This patient was treated with a targeted tyrosine inhibitor

during

> first trimester of a first pregnancy and during the third trimester of a

> second pregnancy. The umbilical cord blood and breast milk findings were:

1)

> low imatinib and metabolite concentration levels found in the umbilical

> blood suggest limited placental transfer in late pregnancy, and 2) HIGH

> CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST

> MILK.

>

> " Rousselot et al (2007) reported imatinib may be discontinued in patients

> who achieved a complete molecular remission for a period of at least 2

years

> without evidence of disease progression.

>

> " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN

> BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in

> infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d);

> considering this milk intake and the infants are unlikely to receive more

> than 3 mg/d imatinib daily. This amount is far from therapeutic range,

> therefore, concluding that mothers with CML could safely breast-feed the

> infant. However, the effects of low-dose chronic exposure of infants to

> imatinib are not known, and have not undergone long-term investigation;

> THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING

THERAPY.

>

> ttp://tinyurl.com/2g82tpc

>

> FYI,

>

> Lottie Duthu

>

>

Link to comment
Share on other sites

Thank u !

Sent via BlackBerry by AT & T

[ ] Breast feeding while on Gleevec

>

> I am gravely concerned about a member who posted recently that she was

> breast feeding her baby while on Gleevec. I want her to know that I am not

> judging her, but merely reiterating what has been passed down to us

> repeately. In speaking directly to her, I hope you have permission, dear

> member from your doctor or you could be playing Russian roulette with your

> baby's health. This is the warning that comes with Gleevec. Women who want

> to become pregnant should not do so while taking Gleevec or any other TKI.

> If you need further proof, I urge you to please contact the Novartis

Hotline

> or the instructions that comes in your package. This comes from their

> webpage:

>

> Who should NOT take GLEEVEC

> Women who are or could be pregnant. Fetal harm can occur when administered

> to pregnant women; therefore, women should not become pregnant, as well as

> be advised of the potential risk to the unborn child if GLEEVEC is used

> during pregnancy.

>

> " Women who are breast-feeding because of the potential for serious adverse

> reactions in nursing infants.

>

> " Sexually active females should use adequate birth control while taking

> GLEEVEC.

>

> " Be sure to talk to your doctor and/or healthcare professional about these

> issues before taking GLEEVEC "

>

> http://tinyurl.com/29fl97v

> --_________________

>

> I further give you warnings from the following information published in

the

> Internet Journal of Oncology. This article was written by Ault

MS,

> RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner

> School of Nursing The University of Texas Health Science Center at Houston

> and I quote from her article (noted in 2010 Volume 7 Number 2).

>

> I have known Pat Ault for a long time, also most of the doctors in that

> department. She would not have been given permission to write this article

> without the blessings of the doctors at MDACC that she works under and I

> respect her authority on the subject of CML.

>

> You will note that everything I copied is in " quotations " . Some quotes I

> have excerpted are posted here, but the entire article can be seen at the

> recited website listed below the quotes, however, it is very lengthy:

>

> " Management of CML during pregnancy poses challenges to both hematologists

> and obstetricians. Currently, consensus is lacking in management of CML in

> pregnancy; therefore, clinical observations have become important. Most of

> these observations are derived from small case series or case reports.

>

> " Therefore, leukapheresis may be an intermittent short-term alternative

> option for pregnant patients, and prevents fetal exposure to TERATOGENIC

> drugs. However, leukapheresis is cumbersome, costly, and a time consuming

> procedure, with risk of infection, thrombosis and hypotensive events that

> may affect the fetus and patient.

> " ........... high concentrations of imatinib are DETECTED IN BREAST MILK.

> " Investigation of the placentas included standard pathologic analysis,

> computer assisted morphometry, and fluorescence in situ hybridization

(FISH)

> analysis. This patient was treated with a targeted tyrosine inhibitor

during

> first trimester of a first pregnancy and during the third trimester of a

> second pregnancy. The umbilical cord blood and breast milk findings were:

1)

> low imatinib and metabolite concentration levels found in the umbilical

> blood suggest limited placental transfer in late pregnancy, and 2) HIGH

> CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST

> MILK.

>

> " Rousselot et al (2007) reported imatinib may be discontinued in patients

> who achieved a complete molecular remission for a period of at least 2

years

> without evidence of disease progression.

>

> " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN

> BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in

> infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d);

> considering this milk intake and the infants are unlikely to receive more

> than 3 mg/d imatinib daily. This amount is far from therapeutic range,

> therefore, concluding that mothers with CML could safely breast-feed the

> infant. However, the effects of low-dose chronic exposure of infants to

> imatinib are not known, and have not undergone long-term investigation;

> THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING

THERAPY.

>

> ttp://tinyurl.com/2g82tpc

>

> FYI,

>

> Lottie Duthu

>

>

Link to comment
Share on other sites

I'm 49 and have received a massive amount of help from this group for almost

5 years.

Jackie

_____

From: [mailto: ] On Behalf Of

Mumminki

Sent: Monday, 4 October 2010 6:18 AM

Subject: Re: [ ] Breast feeding while on Gleevec

I'm done with this group. It should be called CML-support offered to over

60's only, no baby related subjects allowed.

>

> ,

>

> I don't often post, I have trouble on with certain of my computers

but I

> borrowed my friend's Mac because this is not a time for silence. First let

me

> say that I'm sorry you feel that you don't belong in the group. Of course

you

> belong, you have CML. But that is in many cases the only common thread

that

> connects us. Yet we become friends and in many cases family. Who else can

> really understand the path we walk? Friendships are formed here but even

in the

> greatest of friendships there may be disagreements. It appears this is one

such

> time.

>

> You are correct when you say breast feeding is good for children. You are

> correct when you say, it is your decision to continue to breast feed. I

think

> the issue began when you stated that anyone who did not breast feed is a

bad

> mother.

>

> We have enough struggles with our disease without judging each other and

to

> paint us as bad mothers is hurtful.

>

> It appears from your post that you did your research but all the journals

in

> the world cannot predict the future. You say that you are young, then

perhaps

> you are not aware of the drugs that did not impact the mothers but did

give the

> daughters cancer as young women. As parents we are charged to do what is

right

> for our children. We make decisions everyday which hopefully are centered

on

> the needs of the child; not our own.

>

> We are lucky that CML in chronic phase is slow moving. I probably had it

for

> almost two years before diagnosis. While I drink green tea daily and have

for

> about 15 years, I think and it is just my opinion, that you were able to

carry

> your baby to term and remain off meds due to the slow progression which is

the

> hallmark of the disease in chronic phase. The story may have had a

different

> ending if you were in blast phase at diagnosis. I'm not arguing with you,

I have

> no need to be right. I just want you to consider other view points when

you are

> making your decisions.

>

> I can tell you are a loving and caring mother. I guess that this

discussion is

> rendered moot by your statement that you are pretty much dried up and now

just

> breast feed for comfort. Even as non-scientist we have to believe that

something

> that can affect us at a genetic level, as Gleevec does, has to be some

pretty

> strong stuff. You wouldn't take a spoon and feed her a little bit of

poison,

> even 10%. You state how much you love breast feeding, please consider

whose

> needs and comfort are being met, if in fact there is no nutritional value

and

> there may even be harm.

>

> I hope you will stay as a member. I'm sorry if you felt attacked but from

where

> I sit you lobbed the first round- with the bad mother comment. We all are

> connected by our disease. But we can't leave our manners at the door. Are

you

> aware that we have Skip who has had CML for over 30 years? Or that many of

the

> people on this list were in the clinical trials for the very medicine that

is

> keeping you alive? We are fortunate to have a living history of the fight

> against this disease. They have so much knowledge. Please stay and benefit

> from this knowledge.

>

> One final piece of information if you were in the US, your doctor would

probably

> have reported you for child endangerment based on all of the warnings

documented

> by Novartis.

>

> I have no judgement on what kind of a mother you are ; I hope you will

extend

> the same courtesy to the rest of us - we do the best we can and when we

know

> better, the hope is that we will do better. I know I try to do better

everyday.

>

> China

>

>

>

> ________________________________

> From: d'Araille <darajek@...>

> <mailto:%40>

> Sent: Sun, October 3, 2010 7:10:37 AM

> Subject: Re: [ ] Breast feeding while on Gleevec

>

>

> Unfortunately I'm on the same boat as any other member of this group but

not on

> the same page, or rather not even in the same book.

> If you think it was or is easy for me to be diagnosed with cml at 22 weeks

of my

> last pregnancy and be a young mother of 4 kids aged 8, 5, 3 years and 7

months

> you got it all wrong.

> At least most of you have mature families with some grandchildren,

something I

> may not experience my self so I'm making the most of what I've got now.

> The hell with it!

>

>

> From: onthewtr@...

> Sent: Saturday, October 02, 2010 10:19 PM

> <mailto:%40>

> Subject: Re: [ ] Breast feeding while on Gleevec

>

> who r u to make such a strong untrue selfish illiterate statement?

That is

> totally out of line!

>

> Sent via BlackBerry by AT & T

>

> [ ] Breast feeding while on Gleevec

>

> I am gravely concerned about a member who posted recently that she was

> breast feeding her baby while on Gleevec. I want her to know that I am not

> judging her, but merely reiterating what has been passed down to us

> repeately. In speaking directly to her, I hope you have permission, dear

> member from your doctor or you could be playing Russian roulette with your

> baby's health. This is the warning that comes with Gleevec. Women who want

> to become pregnant should not do so while taking Gleevec or any other TKI.

> If you need further proof, I urge you to please contact the Novartis

Hotline

> or the instructions that comes in your package. This comes from their

> webpage:

>

> Who should NOT take GLEEVEC

> Women who are or could be pregnant. Fetal harm can occur when administered

> to pregnant women; therefore, women should not become pregnant, as well as

> be advised of the potential risk to the unborn child if GLEEVEC is used

> during pregnancy.

>

> " Women who are breast-feeding because of the potential for serious adverse

> reactions in nursing infants.

>

> " Sexually active females should use adequate birth control while taking

> GLEEVEC.

>

> " Be sure to talk to your doctor and/or healthcare professional about these

> issues before taking GLEEVEC "

>

> http://tinyurl.com/29fl97v

> --_________________

>

> I further give you warnings from the following information published in

the

> Internet Journal of Oncology. This article was written by Ault

MS,

> RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner

> School of Nursing The University of Texas Health Science Center at Houston

> and I quote from her article (noted in 2010 Volume 7 Number 2).

>

> I have known Pat Ault for a long time, also most of the doctors in that

> department. She would not have been given permission to write this article

> without the blessings of the doctors at MDACC that she works under and I

> respect her authority on the subject of CML.

>

> You will note that everything I copied is in " quotations " . Some quotes I

> have excerpted are posted here, but the entire article can be seen at the

> recited website listed below the quotes, however, it is very lengthy:

>

> " Management of CML during pregnancy poses challenges to both hematologists

> and obstetricians. Currently, consensus is lacking in management of CML in

> pregnancy; therefore, clinical observations have become important. Most of

> these observations are derived from small case series or case reports.

>

> " Therefore, leukapheresis may be an intermittent short-term alternative

> option for pregnant patients, and prevents fetal exposure to TERATOGENIC

> drugs. However, leukapheresis is cumbersome, costly, and a time consuming

> procedure, with risk of infection, thrombosis and hypotensive events that

> may affect the fetus and patient.

> " ........... high concentrations of imatinib are DETECTED IN BREAST MILK.

> " Investigation of the placentas included standard pathologic analysis,

> computer assisted morphometry, and fluorescence in situ hybridization

(FISH)

> analysis. This patient was treated with a targeted tyrosine inhibitor

during

> first trimester of a first pregnancy and during the third trimester of a

> second pregnancy. The umbilical cord blood and breast milk findings were:

1)

> low imatinib and metabolite concentration levels found in the umbilical

> blood suggest limited placental transfer in late pregnancy, and 2) HIGH

> CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST

> MILK.

>

> " Rousselot et al (2007) reported imatinib may be discontinued in patients

> who achieved a complete molecular remission for a period of at least 2

years

> without evidence of disease progression.

>

> " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN

> BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in

> infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d);

> considering this milk intake and the infants are unlikely to receive more

> than 3 mg/d imatinib daily. This amount is far from therapeutic range,

> therefore, concluding that mothers with CML could safely breast-feed the

> infant. However, the effects of low-dose chronic exposure of infants to

> imatinib are not known, and have not undergone long-term investigation;

> THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING

THERAPY.

>

> ttp://tinyurl.com/2g82tpc

>

> FYI,

>

> Lottie Duthu

>

>

Link to comment
Share on other sites

I am 50 and have been here since 42, mother of 3 children, now 20 and 34.  My

twins were 12 when I was diagnosed and it was hard but we have all pulled

through. 

Zavie was there when I needed him when I was first diagnosed on this group!!!!!!

Penny

Have to add one more thing, yes we all have opinions and this is what the group

is for, but not to be hurtful to one another!!! 

From: _ryan.romero@..._ (mailto:ryan.romero@...)   

<_ryan.romero@..._ (mailto:ryan.romero@...) >

Subject:  Re: [ ] Breast feeding while on Gleevec

_ _ (mailto: )

Date: Sunday,  October 3, 2010, 1:13 PM

I'm  28

Thanks

[ ] Breast  feeding while on Gleevec

>

> I am gravely concerned about a  member who posted recently that she was

> breast feeding her baby while  on Gleevec. I want her to know that I am

not

> judging her, but  merely reiterating what has been passed down to us

> repeately. In  speaking directly to her, I hope you have permission, dear

> member  from your doctor or you could be playing Russian roulette with 

your

> baby's health. This is the warning that comes with Gleevec.  Women who

want

> to become pregnant should not do so while taking  Gleevec or any other

TKI.

> If you need further proof, I urge you to  please contact the Novartis

Hotline

> or the instructions that comes  in your package. This comes from their

> webpage:

>

> Who  should NOT take GLEEVEC

> Women who are or could be pregnant. Fetal  harm can occur when

administered

> to pregnant women; therefore,  women should not become pregnant, as well

as

> be advised of the  potential risk to the unborn child if GLEEVEC is used

> during  pregnancy.

>

> " Women who are breast-feeding because of the  potential for serious

adverse

> reactions in nursing infants. 

>

> " Sexually active females should use adequate birth control  while taking

> GLEEVEC.

>

> " Be sure to talk to your  doctor and/or healthcare professional about

these

> issues before  taking GLEEVEC "

>

> _http://tinyurl.com/29fl97v_ (http://tinyurl.com/29fl97v) 

>  --_________________

>

> I further give you warnings from the  following information published in

the

> Internet Journal of  Oncology. This article was written by Ault

MS,

> RN,  FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner

>  School of Nursing The University of Texas Health Science Center at 

Houston

> and I quote from her article (noted in 2010 Volume 7  Number 2).

>

> I have known Pat Ault for a long time, also most  of the doctors in that

> department. She would not have been given  permission to write this

article

> without the blessings of the  doctors at MDACC that she works under and I

> respect her authority on  the subject of CML.

>

> You will note that everything I copied  is in " quotations " . Some quotes I

> have excerpted are posted here, but  the entire article can be seen at

the

> recited website listed below  the quotes, however, it is very lengthy:

>

> " Management of CML  during pregnancy poses challenges to both

hematologists

> and  obstetricians. Currently, consensus is lacking in management of CML 

in

> pregnancy; therefore, clinical observations have become  important. Most

of

> these observations are derived from small case  series or case reports.

>

> " Therefore, leukapheresis may be an  intermittent short-term alternative

> option for pregnant patients, and  prevents fetal exposure to TERATOGENIC

> drugs. However, leukapheresis  is cumbersome, costly, and a time

consuming

> procedure, with risk of  infection, thrombosis and hypotensive events

that

> may affect the  fetus and patient.

> " ........... high concentrations of imatinib are  DETECTED IN BREAST

MILK.

> " Investigation of the placentas included  standard pathologic analysis,

> computer assisted morphometry, and  fluorescence in situ hybridization

(FISH)

> analysis. This patient  was treated with a targeted tyrosine inhibitor

during

> first  trimester of a first pregnancy and during the third trimester of a

>  second pregnancy. The umbilical cord blood and breast milk findings 

were:

1)

> low imatinib and metabolite concentration levels found in  the umbilical

> blood suggest limited placental transfer in late  pregnancy, and 2) HIGH

> CONCENTRATION LEVELS OF IMATINIB AND  METABOLITES WERE FOUND IN THE

BREAST

> MILK.

>

>  " Rousselot et al (2007) reported imatinib may be discontinued in

patients 

> who achieved a complete molecular remission for a period of at least  2

years

> without evidence of disease progression.

>

>  " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION

IN 

> BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk  intake

in

> infants is known to average 728 to 777 ml/d, (range of 450  to 1165

ml/d);

> considering this milk intake and the infants are  unlikely to receive

more

> than 3 mg/d imatinib daily. This amount is  far from therapeutic range,

> therefore, concluding that mothers with  CML could safely breast-feed the

> infant. However, the effects of  low-dose chronic exposure of infants to

> imatinib are not known, and  have not undergone long-term investigation;

> THEREFORE, BREAST FEEDING  SHOULD NOT BE RECOMMENDED AFTER RESUMING

THERAPY.

>

> _ttp://tinyurl.com/2g82tpc_ (ttp://tinyurl.com/2g82tpc) 

> 

> FYI,

>

> Lottie Duthu

>

> [Non-text  portions of this message have been removed]

>

> [Non-text  portions of this message have been removed]

>

> [Non-text  portions of this message have been removed]

>

> [Non-text  portions of this message have been removed]

>

> [Non-text  portions of this message have been removed]

>

> [Non-text  portions of this message have been removed]

>

>

>

> 

>

>

>

> [Non-text portions of this message have  been removed]

>

[Non-text portions of this message have been  removed]

[Non-text portions of this message have been  removed]

[Non-text portions of this message have been  removed]

Link to comment
Share on other sites

I'm only 27 was diagnosed at 21 and joined around 5 years!

Sent from my HTC on the Now Network from Sprint!

----- Reply message -----

From: onthewtr@...

Date: Sun, Oct 3, 2010 6:09 pm

Subject: [ ] Breast feeding while on Gleevec

< >

Link to comment
Share on other sites

, Lots of people here are trying to reach out to you. Having CML

is a VERY difficult journey and it's one you will be living with for a

long time. The people in this group can be a BIG help. I was

diagnosed in 1998 and was in one of the early Gleevec trials. I don't

normally post, but I hope you will continue to receive posts and let

people here help when they can. You're going to have problems as you

go on that others have already walked through. Let everyone help and

remember that we're all " in the same boat, " as we say. We want to

be a help and a solution, not a problem, to others. Things are hard

enough for all of us, as it is.

Gay Bratton

San

On Oct 3, 2010, at 7:42 PM, gilfish_15@... wrote:

> I'm only 27 was diagnosed at 21 and joined around 5 years!

>

> Sent from my HTC on the Now Network from Sprint!

>

> ----- Reply message -----

> From: onthewtr@...

> Date: Sun, Oct 3, 2010 6:09 pm

> Subject: [ ] Breast feeding while on Gleevec

> < >

>

>

Link to comment
Share on other sites

I am 52 - was dx'd at age 46.

I was, and continue to be, a strong breast feeding advocate. I nursed

both my children over 2.5 years each and was a member of La Leche

League.

I say this to put into perspective that I was totally DISMAYED to

read 's aggressive and uncalled for post. I find it ironic that

while she calls for the right of 'freedom of expression' for herself

- no matter how hurtful - she takes offense at those that don't agree

with her!

I have recently joined this chat, after following Jerry's list for a

long time. I have not like the tenor of some of the conversations

there and sought some CML comradeship here.

I think there is room to discuss anything that relates to living with

CML - including pregnancy, baby issues, marriage/relationship issues

et al. However, if we can't post honestly, while still remaining

courteous, this chat cannot survive.

- you are right, if you cannot have a little bit of empathy for

how your unkind words may be read by others and edit them accordingly

(and I say this as one who apparently IS a " fit mother " in your

book), then you don't belong on this list.

You are also right that doctors don't always know everything, BUT

sometimes we must err on the side of caution. I am sorry that you are

not able to comprehend the concern being expressed by the responses

that have been posted, regarding your daughter's well being.

I hope and pray that you are right that your daughter is not

ingesting much milk with Gleevec. I hope and pray that she does not

pay for your tunnel vision in some way in the future.

Leah Peer

Link to comment
Share on other sites

I nursed all three of my kids and I am glad I did. I must confess that as

the result of my reading and the support of La Leche League and other

advocates, I began to think it was tantamount to child abuse to NOT do so. I

would never say so aloud, but inwardly, I felt very sad when a friend would

say she was opting for the bottle. Oh, do I chuckle at my self-righteousness

now! Especially as there was clearly no difference in how our children

developed!

Taking any of the drugs we take sure complicates things. It also requires us

to seek out the learned opinions of specialists in the CML world and the

healthy-baby world. I can't imagine passing judgment on how anyone navigates

this route.

There's a world of difference between making an impassioned personal

statement and lobbing an attack. The first invites people in and the second

pushes them away. I've had to remind myself of this more than once!

This group allows us to discuss such personal things and to feel so

supported. I don't take it for granted for a minute.

On Sun, Oct 3, 2010 at 9:12 AM, china neal <chimera46@...> wrote:

>

>

> ,

>

> I don't often post, I have trouble on with certain of my computers

> but I

> borrowed my friend's Mac because this is not a time for silence. First let

> me

> say that I'm sorry you feel that you don't belong in the group. Of course

> you

> belong, you have CML. But that is in many cases the only common thread that

>

> connects us. Yet we become friends and in many cases family. Who else can

> really understand the path we walk? Friendships are formed here but even in

> the

> greatest of friendships there may be disagreements. It appears this is one

> such

> time.

>

> You are correct when you say breast feeding is good for children. You are

> correct when you say, it is your decision to continue to breast feed. I

> think

> the issue began when you stated that anyone who did not breast feed is a

> bad

> mother.

>

> We have enough struggles with our disease without judging each other and to

>

> paint us as bad mothers is hurtful.

>

> It appears from your post that you did your research but all the journals

> in

> the world cannot predict the future. You say that you are young, then

> perhaps

> you are not aware of the drugs that did not impact the mothers but did give

> the

> daughters cancer as young women. As parents we are charged to do what is

> right

> for our children. We make decisions everyday which hopefully are centered

> on

> the needs of the child; not our own.

>

> We are lucky that CML in chronic phase is slow moving. I probably had it

> for

> almost two years before diagnosis. While I drink green tea daily and have

> for

> about 15 years, I think and it is just my opinion, that you were able to

> carry

> your baby to term and remain off meds due to the slow progression which is

> the

> hallmark of the disease in chronic phase. The story may have had a

> different

> ending if you were in blast phase at diagnosis. I'm not arguing with you, I

> have

> no need to be right. I just want you to consider other view points when you

> are

> making your decisions.

>

> I can tell you are a loving and caring mother. I guess that this discussion

> is

> rendered moot by your statement that you are pretty much dried up and now

> just

> breast feed for comfort. Even as non-scientist we have to believe that

> something

> that can affect us at a genetic level, as Gleevec does, has to be some

> pretty

> strong stuff. You wouldn't take a spoon and feed her a little bit of

> poison,

> even 10%. You state how much you love breast feeding, please consider whose

>

> needs and comfort are being met, if in fact there is no nutritional value

> and

> there may even be harm.

>

> I hope you will stay as a member. I'm sorry if you felt attacked but from

> where

> I sit you lobbed the first round- with the bad mother comment. We all are

> connected by our disease. But we can't leave our manners at the door. Are

> you

> aware that we have Skip who has had CML for over 30 years? Or that many of

> the

> people on this list were in the clinical trials for the very medicine that

> is

> keeping you alive? We are fortunate to have a living history of the fight

> against this disease. They have so much knowledge. Please stay and benefit

> from this knowledge.

>

> One final piece of information if you were in the US, your doctor would

> probably

> have reported you for child endangerment based on all of the warnings

> documented

> by Novartis.

>

> I have no judgement on what kind of a mother you are ; I hope you will

> extend

> the same courtesy to the rest of us - we do the best we can and when we

> know

> better, the hope is that we will do better. I know I try to do better

> everyday.

>

> China

>

> ________________________________

>

> From: d'Araille <darajek@... <darajek%40go2.pl>>

> <%40>

> Sent: Sun, October 3, 2010 7:10:37 AM

>

> Subject: Re: [ ] Breast feeding while on Gleevec

>

> Unfortunately I'm on the same boat as any other member of this group but

> not on

> the same page, or rather not even in the same book.

> If you think it was or is easy for me to be diagnosed with cml at 22 weeks

> of my

> last pregnancy and be a young mother of 4 kids aged 8, 5, 3 years and 7

> months

> you got it all wrong.

> At least most of you have mature families with some grandchildren,

> something I

> may not experience my self so I'm making the most of what I've got now.

> The hell with it!

>

>

> From: onthewtr@... <onthewtr%40discobay.net>

> Sent: Saturday, October 02, 2010 10:19 PM

> <%40>

> Subject: Re: [ ] Breast feeding while on Gleevec

>

> who r u to make such a strong untrue selfish illiterate statement?

> That is

> totally out of line!

>

> Sent via BlackBerry by AT & T

>

> [ ] Breast feeding while on Gleevec

>

> I am gravely concerned about a member who posted recently that she was

> breast feeding her baby while on Gleevec. I want her to know that I am not

> judging her, but merely reiterating what has been passed down to us

> repeately. In speaking directly to her, I hope you have permission, dear

> member from your doctor or you could be playing Russian roulette with your

> baby's health. This is the warning that comes with Gleevec. Women who want

> to become pregnant should not do so while taking Gleevec or any other TKI.

> If you need further proof, I urge you to please contact the Novartis

> Hotline

> or the instructions that comes in your package. This comes from their

> webpage:

>

> Who should NOT take GLEEVEC

> Women who are or could be pregnant. Fetal harm can occur when administered

> to pregnant women; therefore, women should not become pregnant, as well as

> be advised of the potential risk to the unborn child if GLEEVEC is used

> during pregnancy.

>

> " Women who are breast-feeding because of the potential for serious adverse

> reactions in nursing infants.

>

> " Sexually active females should use adequate birth control while taking

> GLEEVEC.

>

> " Be sure to talk to your doctor and/or healthcare professional about these

> issues before taking GLEEVEC "

>

> http://tinyurl.com/29fl97v

> --_________________

>

> I further give you warnings from the following information published in the

>

> Internet Journal of Oncology. This article was written by Ault MS,

>

> RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner

> School of Nursing The University of Texas Health Science Center at Houston

> and I quote from her article (noted in 2010 Volume 7 Number 2).

>

> I have known Pat Ault for a long time, also most of the doctors in that

> department. She would not have been given permission to write this article

> without the blessings of the doctors at MDACC that she works under and I

> respect her authority on the subject of CML.

>

> You will note that everything I copied is in " quotations " . Some quotes I

> have excerpted are posted here, but the entire article can be seen at the

> recited website listed below the quotes, however, it is very lengthy:

>

> " Management of CML during pregnancy poses challenges to both hematologists

> and obstetricians. Currently, consensus is lacking in management of CML in

> pregnancy; therefore, clinical observations have become important. Most of

> these observations are derived from small case series or case reports.

>

> " Therefore, leukapheresis may be an intermittent short-term alternative

> option for pregnant patients, and prevents fetal exposure to TERATOGENIC

> drugs. However, leukapheresis is cumbersome, costly, and a time consuming

> procedure, with risk of infection, thrombosis and hypotensive events that

> may affect the fetus and patient.

> " ........... high concentrations of imatinib are DETECTED IN BREAST MILK.

> " Investigation of the placentas included standard pathologic analysis,

> computer assisted morphometry, and fluorescence in situ hybridization

> (FISH)

> analysis. This patient was treated with a targeted tyrosine inhibitor

> during

> first trimester of a first pregnancy and during the third trimester of a

> second pregnancy. The umbilical cord blood and breast milk findings were:

> 1)

> low imatinib and metabolite concentration levels found in the umbilical

> blood suggest limited placental transfer in late pregnancy, and 2) HIGH

> CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST

> MILK.

>

> " Rousselot et al (2007) reported imatinib may be discontinued in patients

> who achieved a complete molecular remission for a period of at least 2

> years

> without evidence of disease progression.

>

> " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN

> BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in

> infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d);

> considering this milk intake and the infants are unlikely to receive more

> than 3 mg/d imatinib daily. This amount is far from therapeutic range,

> therefore, concluding that mothers with CML could safely breast-feed the

> infant. However, the effects of low-dose chronic exposure of infants to

> imatinib are not known, and have not undergone long-term investigation;

> THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING THERAPY.

>

>

> ttp://tinyurl.com/2g82tpc

>

> FYI,

>

> Lottie Duthu

>

>

Link to comment
Share on other sites

38 been here 3 years.

Tammy

From: andrea silveira [mailto:formiga101@...]

Sent: Sunday, October 03, 2010 5:43 PM

Subject: Re: [ ] Breast feeding while on Gleevec

I am 29 and have been part of this group almost 7 years

From: ryan.romero@... <mailto:ryan.romero%40callfusion.com>

<ryan.romero@... <mailto:ryan.romero%40callfusion.com> >

Subject: Re: [ ] Breast feeding while on Gleevec

<mailto:%40>

Date: Sunday, October 3, 2010, 1:13 PM

I'm 28

Thanks

[ ] Breast feeding while on Gleevec

>

> I am gravely concerned about a member who posted recently that she was

> breast feeding her baby while on Gleevec. I want her to know that I am not

> judging her, but merely reiterating what has been passed down to us

> repeately. In speaking directly to her, I hope you have permission, dear

> member from your doctor or you could be playing Russian roulette with your

> baby's health. This is the warning that comes with Gleevec. Women who want

> to become pregnant should not do so while taking Gleevec or any other TKI.

> If you need further proof, I urge you to please contact the Novartis

Hotline

> or the instructions that comes in your package. This comes from their

> webpage:

>

> Who should NOT take GLEEVEC

> Women who are or could be pregnant. Fetal harm can occur when administered

> to pregnant women; therefore, women should not become pregnant, as well as

> be advised of the potential risk to the unborn child if GLEEVEC is used

> during pregnancy.

>

> " Women who are breast-feeding because of the potential for serious adverse

> reactions in nursing infants.

>

> " Sexually active females should use adequate birth control while taking

> GLEEVEC.

>

> " Be sure to talk to your doctor and/or healthcare professional about these

> issues before taking GLEEVEC "

>

> http://tinyurl.com/29fl97v

> --_________________

>

> I further give you warnings from the following information published in

the

> Internet Journal of Oncology. This article was written by Ault

MS,

> RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner

> School of Nursing The University of Texas Health Science Center at Houston

> and I quote from her article (noted in 2010 Volume 7 Number 2).

>

> I have known Pat Ault for a long time, also most of the doctors in that

> department. She would not have been given permission to write this article

> without the blessings of the doctors at MDACC that she works under and I

> respect her authority on the subject of CML.

>

> You will note that everything I copied is in " quotations " . Some quotes I

> have excerpted are posted here, but the entire article can be seen at the

> recited website listed below the quotes, however, it is very lengthy:

>

> " Management of CML during pregnancy poses challenges to both hematologists

> and obstetricians. Currently, consensus is lacking in management of CML in

> pregnancy; therefore, clinical observations have become important. Most of

> these observations are derived from small case series or case reports.

>

> " Therefore, leukapheresis may be an intermittent short-term alternative

> option for pregnant patients, and prevents fetal exposure to TERATOGENIC

> drugs. However, leukapheresis is cumbersome, costly, and a time consuming

> procedure, with risk of infection, thrombosis and hypotensive events that

> may affect the fetus and patient.

> " ........... high concentrations of imatinib are DETECTED IN BREAST MILK.

> " Investigation of the placentas included standard pathologic analysis,

> computer assisted morphometry, and fluorescence in situ hybridization

(FISH)

> analysis. This patient was treated with a targeted tyrosine inhibitor

during

> first trimester of a first pregnancy and during the third trimester of a

> second pregnancy. The umbilical cord blood and breast milk findings were:

1)

> low imatinib and metabolite concentration levels found in the umbilical

> blood suggest limited placental transfer in late pregnancy, and 2) HIGH

> CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST

> MILK.

>

> " Rousselot et al (2007) reported imatinib may be discontinued in patients

> who achieved a complete molecular remission for a period of at least 2

years

> without evidence of disease progression.

>

> " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN

> BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in

> infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d);

> considering this milk intake and the infants are unlikely to receive more

> than 3 mg/d imatinib daily. This amount is far from therapeutic range,

> therefore, concluding that mothers with CML could safely breast-feed the

> infant. However, the effects of low-dose chronic exposure of infants to

> imatinib are not known, and have not undergone long-term investigation;

> THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING

THERAPY.

>

> ttp://tinyurl.com/2g82tpc

>

> FYI,

>

> Lottie Duthu

>

>

Link to comment
Share on other sites

Please remove my email from this list.

Thanks.

[ ] Breast feeding while on Gleevec

>

> I am gravely concerned about a member who posted recently that she was

> breast feeding her baby while on Gleevec. I want her to know that I am not

> judging her, but merely reiterating what has been passed down to us

> repeately. In speaking directly to her, I hope you have permission, dear

> member from your doctor or you could be playing Russian roulette with your

> baby's health. This is the warning that comes with Gleevec. Women who want

> to become pregnant should not do so while taking Gleevec or any other TKI.

> If you need further proof, I urge you to please contact the Novartis

Hotline

> or the instructions that comes in your package. This comes from their

> webpage:

>

> Who should NOT take GLEEVEC

> Women who are or could be pregnant. Fetal harm can occur when administered

> to pregnant women; therefore, women should not become pregnant, as well as

> be advised of the potential risk to the unborn child if GLEEVEC is used

> during pregnancy.

>

> " Women who are breast-feeding because of the potential for serious adverse

> reactions in nursing infants.

>

> " Sexually active females should use adequate birth control while taking

> GLEEVEC.

>

> " Be sure to talk to your doctor and/or healthcare professional about these

> issues before taking GLEEVEC "

>

> http://tinyurl.com/29fl97v

> --_________________

>

> I further give you warnings from the following information published in

the

> Internet Journal of Oncology. This article was written by Ault

MS,

> RN, FNP-BC, ANP-BC Family Nurse Practitioner, Adult Nurse Practitioner

> School of Nursing The University of Texas Health Science Center at Houston

> and I quote from her article (noted in 2010 Volume 7 Number 2).

>

> I have known Pat Ault for a long time, also most of the doctors in that

> department. She would not have been given permission to write this article

> without the blessings of the doctors at MDACC that she works under and I

> respect her authority on the subject of CML.

>

> You will note that everything I copied is in " quotations " . Some quotes I

> have excerpted are posted here, but the entire article can be seen at the

> recited website listed below the quotes, however, it is very lengthy:

>

> " Management of CML during pregnancy poses challenges to both hematologists

> and obstetricians. Currently, consensus is lacking in management of CML in

> pregnancy; therefore, clinical observations have become important. Most of

> these observations are derived from small case series or case reports.

>

> " Therefore, leukapheresis may be an intermittent short-term alternative

> option for pregnant patients, and prevents fetal exposure to TERATOGENIC

> drugs. However, leukapheresis is cumbersome, costly, and a time consuming

> procedure, with risk of infection, thrombosis and hypotensive events that

> may affect the fetus and patient.

> " ........... high concentrations of imatinib are DETECTED IN BREAST MILK.

> " Investigation of the placentas included standard pathologic analysis,

> computer assisted morphometry, and fluorescence in situ hybridization

(FISH)

> analysis. This patient was treated with a targeted tyrosine inhibitor

during

> first trimester of a first pregnancy and during the third trimester of a

> second pregnancy. The umbilical cord blood and breast milk findings were:

1)

> low imatinib and metabolite concentration levels found in the umbilical

> blood suggest limited placental transfer in late pregnancy, and 2) HIGH

> CONCENTRATION LEVELS OF IMATINIB AND METABOLITES WERE FOUND IN THE BREAST

> MILK.

>

> " Rousselot et al (2007) reported imatinib may be discontinued in patients

> who achieved a complete molecular remission for a period of at least 2

years

> without evidence of disease progression.

>

> " Gambacorti-Passerini et al (2009) reported the IMATINIB CONCENTRATION IN

> BREAST MILK REACHES A STEADY-STATE LEVEL AT 0.8 ug/ml. The milk intake in

> infants is known to average 728 to 777 ml/d, (range of 450 to 1165 ml/d);

> considering this milk intake and the infants are unlikely to receive more

> than 3 mg/d imatinib daily. This amount is far from therapeutic range,

> therefore, concluding that mothers with CML could safely breast-feed the

> infant. However, the effects of low-dose chronic exposure of infants to

> imatinib are not known, and have not undergone long-term investigation;

> THEREFORE, BREAST FEEDING SHOULD NOT BE RECOMMENDED AFTER RESUMING

THERAPY.

>

> ttp://tinyurl.com/2g82tpc

>

> FYI,

>

> Lottie Duthu

>

>

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...